BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Martin Steegmaier(Boehringer Ingelheim (Austria)), Matthias Hoffmann(Boehringer Ingelheim (Germany)), Anke Baum(Boehringer Ingelheim (Austria)), Péter Lénárt(Research Institute of Molecular Pathology), Mark Petronczki(Research Institute of Molecular Pathology), Martin Krššák(Boehringer Ingelheim (Austria)), Ulrich Gürtler(Boehringer Ingelheim (Austria)), Pilar Garin‐Chesa(Boehringer Ingelheim (Austria)), Simone Lieb(Boehringer Ingelheim (Austria)), Jens Quant(Boehringer Ingelheim (Austria)), Matthias Grauert(Boehringer Ingelheim (Germany)), Günther R. Adolf(Boehringer Ingelheim (Austria)), Norbert Kraut(Boehringer Ingelheim (Austria)), Jan‐Michael Peters(Research Institute of Molecular Pathology), Wolfgang J. Rettig(Boehringer Ingelheim (Austria))
Cited by 849Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis